← FDA Drug Approvals (Drugs@FDA)

RIVASTIGMINE TARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2014-08-22

Drug application

FDA Application #

ANDA203148

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIVASTIGMINE TARTRATE

Generic name

RIVASTIGMINE TARTRATE

Active ingredients

RIVASTIGMINE TARTRATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

MACLEODS PHARMS LTD

Manufacturer

Macleods Pharmaceuticals Limited

First approval

2014-08-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown